PeekMed closed a €3 million (~USD $3.6 million) Series A investment round. Funds will support global expansion, especially in Europe and North America, where PeekMed will increase sales & marketing capacity and its product implementation team.
Proceeds will also focus on further development of 3D Artificial Intelligence planning and Deep Learning technologies.
PeekMed has developed its surgical planning system that employs 3D and artificial intelligence technology. The system allows the planning of surgery and simulation of different outcomes and implant sizes in seconds.
PeekMed's technology is approved under the CE Mark and FDA 510(k) cleared. In 1Q21, the company signed an agreement whereby GOeasy will promote PeekMed’s Artificial Intelligence-based pre-operative planning solution through its international direct and indirect sales network.
João Pedro Ribeiro, CEO & Chairman of PeekMed, said, “Since day one our vision has been to support surgeons, hospitals and implant manufacturers to better prepare and simulate surgeries, ultimately leading to cost reduction and better outcomes for the patient...With the product already developed and multiple contracts in place, now is the time to expand our market reach and our product’s capabilities.”